Johnson & Johnson's Ottava Robotic System Wins US Approval, Challenging Intuitive Surgical's Dominance
Johnson & Johnson has secured US regulatory approval for its Ottava robotic surgical system, marking the company's entry into the rapidly expanding soft-tissue robotic surgery market. The device competes against Intuitive Surgical's market-leading da Vinci system.